A Washington Post editorial today warns us that allowing Medicare to negotiate prices directly with the pharmaceutical industry would be "a sure way of flooding the political system with yet more pharmaceutical lobbyists and campaign spending."
Those of us who live in Washington know that the industry already floods the political system in order to preserve and strengthen the government granted patent protection that allows them to charge monopoly prices. Taking the money away will reduce, not increase, the number of lobbyists.
If you enjoyed this article, please consider making a tax-deductible donation today. For over 30 years, The American Prospect has delivered independent reporting that exposes corporate power, investigates political corruption, and analyzes threats to our democracy. Unlike many media outlets, we’re not owned by billionaires or corporations—we’re powered by readers like you.
Today’s independent journalism faces unprecedented challenges. Your support makes our reporting possible and keeps our work free and accessible to all. Whether it’s $5 or $50, every contribution helps sustain our nonprofit newsroom.
Join our community of supporters and make a donation today to help keep independent journalism thriving.
Copyright 2025 | The American Prospect, Inc. | All Rights Reserved
